Photo of Birte Wistinghausen
Accepting New Patients

Birte Wistinghausen, MD Email Birte Wistinghausen

Doctor magenta, checkmark badge icon
Mount Sinai Doctors Faculty Practice ?
    • Position
    • ASSOCIATE PROFESSOR | Pediatrics
    • Specialties
    • Pediatrics
    • Pediatric Hematology-Oncology
    • Languages
    • English
    • German
    • Hospital Affiliations
    • The Mount Sinai Hospital
    • Mount Sinai Beth Israel
    • Phone
    • Pediatric Hematology and Oncology 212-241-7022
Request an Appointment
Annenberg Building 1468 Madison Avenue, 4th Floor
New York, NY 10029
Phone: 212-241-7022

Dr. Birte Wistinghausen is the Medical Director of the Division of Pediatric Hematology-Oncology, and Associate Professor of Hematology-Oncology at the Kravis Children's Hospital and Icahn School of Medicine at Mount Sinai. 

Dr. Wistinghausen earned her medical degree at Christian-Albrecht Universitat Kiel in 1993. After a two-year postdoctoral fellowship in the laboratory of Dr. Margaret Karpatkin describing a novel mutation leading to factor IX deficiency she went on to complete an internship and a residency in Pediatrics at New York University Medical Center in New York.  She completed her fellowship in pediatric hematology-oncology at New York University Medical Center and Bellevue Hospital and received her first faculty appointment at New York University Medical Center.

As Clinical Director of Pediatric Hematology and Oncology, Dr. Wistinghausen specializes in diagnosing and treating pediatric patients with leukemia, lymphoma, Langerhans cell histiocytosis and pediatric solid tumors as well as treating selected benign hematological problems of childhood such as ITP, hemophagocytic lymphohistiocytosis (HLH) and hematological complications of solid organ transplantation.  Dr. Wistinghausen’s research interests focus on clinical and translational research in non-Hodgkin lymphoma and post-transplant lymphoproliferative disease (PTLD). She currently serves as the institutional principal investigator for the Children’s Oncology Group and is a member of the NHL committee of the Children’s Oncology Committee where she has been appointed to spearhead the clinical research for B-lymphoblastic lymphoma in childhood and to develop a new national clinical and translational research protocol for the treatment of post-transplant lymphoproliferative disease with cellular based therapies. Dr. Wistinghausen has published articles about factor XI deficiency, hematological complications of solid organ transplantation, HLH and PTLD.



Pediatric Hematology & Oncology

Clinical Focus

  • Ewing Sarcoma
  • Osteogenic sarcoma
  • Pediatric brain tumors
  • Post transplant lymphoproliferative disease (PTLD)


MD, Christian-Albrecht Universitat

Residency, Pediatrics
Bellevue Hospital Center

Fellowship, Pediatrics/Hemo/Onc.
Bellevue Hospital Center


English, German